| Literature DB >> 34233951 |
Steven Rodriguez1,2, Asli Sahin1, Benjamin R Schrank1, Hawra Al-Lawati1, Isabel Costantino1, Eric Benz1, Darian Fard1, Alefiya D Albers1,3, Luxiang Cao1, Alexis C Gomez1, Kyle Evans1,2, Elena Ratti1, Merit Cudkowicz1, Matthew P Frosch4, Michael Talkowski1,5, Peter K Sorger2, Bradley T Hyman1, Mark W Albers6,2.
Abstract
Triggers of innate immune signaling in the CNS of patients with amyotrophic lateral sclerosis and frontotemporal degeneration (ALS/FTD) remain elusive. We report the presence of cytoplasmic double-stranded RNA (cdsRNA), an established trigger of innate immunity, in ALS-FTD brains carrying C9ORF72 intronic hexanucleotide expansions that included genomically encoded expansions of the G4C2 repeat sequences. The presence of cdsRNA in human brains was coincident with cytoplasmic TAR DNA binding protein 43 (TDP-43) inclusions, a pathologic hallmark of ALS/FTD. Introducing cdsRNA into cultured human neural cells induced type I interferon (IFN-I) signaling and death that was rescued by FDA-approved JAK inhibitors. In mice, genomically encoded dsRNAs expressed exclusively in a neuronal class induced IFN-I and death in connected neurons non-cell-autonomously. Our findings establish that genomically encoded cdsRNAs trigger sterile, viral-mimetic IFN-I induction and propagated death within neural circuits and may drive neuroinflammation and neurodegeneration in patients with ALS/FTD.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34233951 PMCID: PMC8779652 DOI: 10.1126/scitranslmed.aaz4699
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956